Vimarsana
Biggest News Aggregation in the World

Page 26 - Alacyclovir News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Alacyclovir. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Alacyclovir Today - Breaking & Trending Today

As CDC Holds the Line, Doctors Debate Lifting School Mask Mandates - Vimarsana News

As CDC Holds the Line, Doctors Debate Lifting School Mask Mandates

Physicians have highly varied views on whether it's the right time to drop masks or whether doing so would set the nation back.

Merck to Deliver 3.1 Million Treatment Courses of COVID Antiviral - Vimarsana News

Merck to Deliver 3.1 Million Treatment Courses of COVID Antiviral

In June, the US government agreed to buy 1.7 million courses of molnupiravir for $1.2 billion and in November agreed to buy an additional 1.4 billion courses for $1 billion.

Remdesivir Takes Top Spot for US Hospital Spending: Report - Vimarsana News

Remdesivir Takes Top Spot for US Hospital Spending: Report

The COVID-19 drug remdesivir last year overtook AbbVie's 20-year-old arthritis drug Humira as the medicine that US hospitals spent the most on.

NYC Offering Free COVID-19 Antiviral Pills to Residents - Vimarsana News

NYC Offering Free COVID-19 Antiviral Pills to Residents

Residents can receive same-day deliveries of the Pfizer product Paxlovid or the Merck product molnupiravir while supplies last.

EU Drug Regulator OKs Pfizer COVID Pill for High-Risk Patients - Vimarsana News

EU Drug Regulator OKs Pfizer COVID Pill for High-Risk Patients

The European Union's drug regulator on Thursday gave the green light to Pfizer Inc's antiviral COVID-19 pill for treating adults at risk of severe illness, as the region scrambles to boost its arsenal to fight the Omicron variant.